ReviewBMJ global health2023
Reconceptualising the commercial determinants of health: bringing institutions in.
Review in BMJ global health, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed.
- Reviewing ecosystems of evidence: synthesising the evidence on the commercial determinants of health from a complex systems perspective.Systematic reviews · 2026Article
- Non-governmental organisations and the regulation of harmful commodity industries: navigating global governance to change corporate practices.Globalization and health · 2026Article
- The end of the garden path? Analyzing smallholder tobacco farming income and decision-making in Mozambique.Globalization and health · 2026Article
- Climate Vulnerability Index and Incident Type 2 Diabetes in a Large Integrated Health Care System.JAMA network open · 2025Article
- Oral Health Meets Commercial Determinants: An Opportunity to Bridge Individual and Structural Approaches.Australian dental journal · 2025Review
- Constructing and contesting industry's role in multistakeholder governance: a qualitative analysis of responses to WHO consultations.Globalization and health · 2025Article
- Demystifying Commercial Influences on Health: Applying Systems Dynamics Methodologies to Policy Processes Comment on "Using System Dynamics to Understand Transnational Corporate Power in Diet-Related Non-communicable Disease Prevention Policy-Making: A Case Study of South Africa".International journal of health policy and management · 2025Article
- Evaluating campaign concepts aimed at replacing sugar-sweetened beverages with water.Health promotion journal of Australia : official journal of Australian Association of Health Promotion Professionals · 2025Article
- Aligning rhetoric with reality: a qualitative analysis of multistakeholder initiatives in the global food system.Health promotion international · 2024Article
- Can health impact assessment help tackle commercial determinants of health and support a wellbeing economy?Health promotion international · 2024Review
- Industry influence on public health policy formulation in the UK: a complex systems approach.Health promotion international · 2024Article
- Continuities and change in alcohol policy at the global level: a documentary analysis of the 2010 Global Strategy for Reducing the Harmful Use of Alcohol and the Global Alcohol Action Plan 2022-2030.Globalization and health · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
The concept of the 'commercial determinants of health' (CDOH) has been developed by public health researchers as a way to describe the political economy of corporations and the impact of their practices on health, social inequalities and climate change. In this analysis, we assess the conceptual work that has developed this field and the influence of the more established 'social determinants of health' models. We highlight the dominance of epidemiologic and biomedical concepts on understandings of structure and agency in the CDOH literature and argue that the terminology of 'risk factors', 'drivers' and 'pathways' reflects an agent-centred approach. We suggest that, as a result, there is a tendency to overlook the importance of political institutions in shaping the exercise of corporate power. Our analysis seeks to 'bring institutions in' to CDOH research, using the empirical cases of Health in All Policies and Better Regulation in the European Union to highlight how institutional contexts shape political legitimacy and accountability, and in turn the strategies of corporate actors. Institutionalist approaches, we argue, have the potential to develop and expand understandings of CDOH by opening the black box between agency and structure.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.